NNMX — Nanomix Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Nanomix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.6 | -3.69 | -0.908 | -9.47 | -12.3 |
| Depreciation | |||||
| Non-Cash Items | 1.94 | 0.056 | -0.308 | 3.2 | 5.38 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.615 | 2.29 | 0.431 | -0.114 | 0.782 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.884 | -1.2 | -0.784 | -6.32 | -6.09 |
| Capital Expenditures | 0 | — | — | -0.336 | -0.027 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.004 | 0 | — | 0.063 | 0.212 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.004 | 0 | — | -0.273 | 0.186 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.755 | 1.19 | 0.785 | 6.87 | 5.62 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.125 | -0.006 | 0.001 | 0.282 | -0.28 |